A nomogram based on conventional and contrast-enhanced ultrasound radiomics for the noninvasively prediction of axillary lymph node metastasis in breast cancer patients

被引:0
作者
Sun, Chao [1 ]
Gong, Xuantong [1 ]
Hou, Lu [2 ]
Yang, Di [1 ]
Li, Qian [3 ]
Li, Lin [4 ]
Wang, Yong [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Ultrasound, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Canc Hosp, Dept Rad Oncol,Natl Canc Ctr, Beijing, Peoples R China
[3] Zhengzhou Univ, Affiliated Canc Hosp, Dept Ultrasound, Zhengzhou, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Dept Diagnost Radiol, Natl Clin Res Ctr Canc, Canc Hosp,Natl Canc Ctr, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
基金
中国博士后科学基金;
关键词
axillary lymph node; breast cancer; radiomics; conventional ultrasound; contrast-enhanced ultrasound; BIOPSY; FEATURES; US; COMPLICATIONS; DISSECTION; DIAGNOSIS;
D O I
10.3389/fonc.2024.1400872
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background This study aimed to investigate whether quantitative radiomics features extracted from conventional ultrasound (CUS) and contrast-enhanced ultrasound (CEUS) of primary breast lesions can help noninvasively predict axillary lymph nodes metastasis (ALNM) in breast cancer patients.Method A total of 111 breast cancer patients with 111 breast lesions were prospectively enrolled. All the included patients received presurgical CUS screening and CEUS examination and were randomly assigned to the training and validation sets at a ratio of 7:3 (n = 78 versus 33). Radiomics features were respectively extracted based on CUS and CEUS using the PyRadiomics package. The max-relevance and min-redundancy (MRMR) and least absolute shrinkage and selection operator (LASSO) analyses were used for feature selection and radiomics score calculation in the training set. The variance inflation factor (VIF) was performed to check the multicollinearity among selected predictors. The best performing model was selected to develop a nomogram using binary logistic regression analysis. The calibration and clinical utility of the nomogram were assessed.Results The model combining CUS reported ALN status, CUS radiomics score (CUS-radscore) and CEUS radiomics score (CEUS-radscore) exhibited the best performance. The areas under the curves (AUC) of our proposed nomogram in the training and external validation sets were 0.845 [95% confidence interval (CI), 0.739-0.950] and 0.901 (95% CI, 0.758-1). The calibration curves and decision curve analysis (DCA) demonstrated the nomogram's robust consistency and clinical utility.Conclusions The established nomogram is a promising prediction tool for noninvasive prediction of ALN status. The radiomics features based on CUS and CEUS can help improve the predictive performance.
引用
收藏
页数:11
相关论文
共 40 条
  • [1] Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer:: A systematic review
    Alvarez, S
    Añorbe, E
    Alcorta, P
    López, F
    Alonso, I
    Cortés, J
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2006, 186 (05) : 1342 - 1348
  • [2] Association between US features of primary tumor and axillary lymph node metastasis in patients with clinical T1-T2N0 breast cancer
    Bae, Min Sun
    Shin, Sung Ui
    Song, Sung Eun
    Ryu, Han Suk
    Han, Wonshik
    Moon, Woo Kyung
    [J]. ACTA RADIOLOGICA, 2018, 59 (04) : 402 - 408
  • [3] Artificial intelligence in cancer imaging: Clinical challenges and applications
    Bi, Wenya Linda
    Hosny, Ahmed
    Schabath, Matthew B.
    Giger, Maryellen L.
    Birkbak, Nicolai J.
    Mehrtash, Alireza
    Allison, Tavis
    Arnaout, Omar
    Abbosh, Christopher
    Dunn, Ian F.
    Mak, Raymond H.
    Tamimi, Rulla M.
    Tempany, Clare M.
    Swanton, Charles
    Hoffmann, Udo
    Schwartz, Lawrence H.
    Gillies, Robert J.
    Huang, Raymond Y.
    Aerts, Hugo J. W. L.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (02) : 127 - 157
  • [4] Metastatic profiles and survival differences between infiltrating ductal carcinoma and infiltrating lobular carcinoma in invasive breast cancer
    Cavaller, L.
    Goupille, C.
    Arbion, F.
    Vilde, A.
    Body, G.
    Ouldamer, L.
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2024, 53 (04)
  • [5] AXILLARY LYMPH NODE SONOGRAPHIC FEATURES AND BREAST TUMOR CHARACTERISTICS AS PREDICTORS OF MALIGNANCY: A NOMOGRAM TO PREDICT RISK
    de Camargo Teixeira, Patricia Akissue
    Chala, Luciano F.
    Shimizu, Carlos
    Filassi, Jose R.
    Maesaka, Jonathan Y.
    de Barros, Nestor
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 2017, 43 (09) : 1837 - 1845
  • [6] Cancer statistics for African Americans, 2019
    DeSantis, Carol E.
    Miller, Kimberly D.
    Sauer, Ann Goding
    Jemal, Ahmedin
    Siegel, Rebecca L.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (03) : 211 - 233
  • [7] Cancer Treatment and Survivorship Statistics, 2014
    DeSantis, Carol E.
    Lin, Chun Chieh
    Mariotto, Angela B.
    Siegel, Rebecca L.
    Stein, Kevin D.
    Kramer, Joan L.
    Alteri, Rick
    Robbins, Anthony S.
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (04) : 252 - 271
  • [8] Combining primary tumor features derived from conventional and contrast-enhanced ultrasound facilitates the prediction of positive axillary lymph nodes in Breast Imaging Reporting and Data System category 4 malignant breast lesions
    Du, Yu
    Yi, Chun-Bei
    Du, Li -Wen
    Gong, Hai-Yan
    Ling, Li -Jun
    Ye, Xin-Hua
    Zong, Min
    Li, Cui-Ying
    [J]. DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2023, 29 (03): : 469 - 477
  • [9] A Comparison of the Clinicopathological Features, Metastasis Sites and Survival Outcomes of Invasive Lobular, Invasive Ductal and Mixed Invasive Ductal and Lobular Breast Carcinoma
    Duraker, Nuvit
    Hot, Semih
    Akan, Arzu
    Nayir, Pinar Ozay
    [J]. EUROPEAN JOURNAL OF BREAST HEALTH, 2020, 16 (01) : 22 - 31
  • [10] Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled, phase 3 trial
    Galimberti, Viviana
    Cole, Bernard F.
    Viale, Giuseppe
    Veronesi, Paolo
    Vicini, Elisa
    Intra, Mattia
    Mazzarol, Giovanni
    Massarut, Samuele
    Zgajnar, Janez
    Taffurelli, Mario
    Littlejohn, David
    Knauer, Michael
    Tondini, Carlo
    Di Leo, Angelo
    Colleoni, Marco
    Regan, Meredith M.
    Coates, Alan S.
    Gelber, Richard D.
    Goldhirsch, Aron
    [J]. LANCET ONCOLOGY, 2018, 19 (10) : 1385 - 1393